Market›Health Care›Health Care Providers & Services›Health Care Distributors
SINOPHARM GROUP CO ADR

SHTDY

$12.50Apr 26, 2021 – Apr 24, 2026
Health CareHealth Care Providers & ServicesHealth Care Distributors$8.31B
MVM
-$12.5M
TD Variance
-10.000

Every news event mapped to its market reaction — 23 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-11-21-6.6%earningsSeeking AlphaSinopharm Group: The Focus Is On Working Capital And Profitability
2024-06-17-4.9%newsSeeking AlphaSinopharm Group Co. Ltd. goes ex dividend tomorrow
2021-09-03+3.5%newsSeeking AlphaChina is struggling to expand COVID-19 vaccination drive - official
2025-04-17+3.4%earningsSeeking AlphaSinopharm Group: Mixed Read-Throughs From Peer Disclosures And Management Guidance
2022-10-07+2.9%newsSeeking AlphaU.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries
2021-08-02+2.8%newsSeeking AlphaSinopharm COVID-19 shot offers a lower antibody response against Delta variant - study
2022-02-07+2.5%newsSeeking AlphaSouth African regulator registers Chinese Sinopharm vaccine, Pfizer/BioNTech's COMIRNATY
2021-09-17+2.3%newsSeeking AlphaSmall study indicates benefit of Sinopharm COVID booster shot
2022-04-08+2.2%newsSeeking AlphaSupply chain on watch as Shanghai lockdown grows in severity
2023-02-24-2.2%newsSeeking AlphaGE HealthCare and Sinopharm to form joint venture in China
2026-03-19+2.0%newsPR NewswireWoori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
2026-03-19+2.0%newsACCESS NewswireWoori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities
2023-01-20-1.7%newsSeeking AlphaSinopharm unit cleared to study first mRNA COVID shot in China
2025-09-03-1.6%newsQuiver QuantitativeSheri Biggs Net Worth - Quiver Quantitative
2021-05-08-1.5%newsTradingViewSinopharm Group Co., Ltd. Unsponsored ADR Class H Trade Ideas — OTC:SHTDY - TradingView
2026-03-21-1.4%newsSimply Wall St.Sinopharm Explores Noninvasive Glucose Monitoring To Deepen China Diabetes Role
2021-10-12-1.3%newsSeeking AlphaWHO recommends an additional COVID-19 vaccine for immunocompromised people
2023-04-13-1.2%newsSeeking AlphaPfizer collaborates with Sinopharm to expand in China
2022-07-07-0.6%M&ASeeking AlphaSinopharm mulls $1B acquisition of Shanghai-based BBI Life Sciences - Bloomberg
2023-01-11-0.3%newsSeeking AlphaMerck mulls legal action against unsanctioned distributors of its COVID drug in China
2024-06-03+0.1%analystSeeking AlphaSinopharm Group: External Headwinds And Re-Rating Drivers Draw Attention
2021-07-12-0.0%newsSeeking AlphaSinopharm: Good Share Price Run Has Halted
2021-07-12-0.0%newsSeeking AlphaChinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says
tickerdossier.comtickerdossier.substack.com